Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB

Drug Development and Industrial Pharmacy

Volumn 41, Issue 3, 2015, Pages 353-361

  Liu, Zhidong ^a,b   Zhao, Hainan ^a,b,c   Shu, Lexin ^a,b   Zhang, Yanqing ^d   Okeke, Chukwunweikeikechukwu ^a,b   Zhang, Li ^a,b   Li, Jiawei ^a,b   Li, Nan ^a,b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d TIANJIN UNIVERSITY OF COMMERCE   (China)

Author keywords

Baicalin; BBB; Brain target drug delivery; Cationic solid lipid nanoparticles; OX26

Indexed keywords

ANTACID AGENT; BIOCERAMICS; CALCIUM OXIDE; LYSOZYME; MICROSPHERE; PHOSPHORUS PENTOXIDE; POLYGLACTIN; SILICON DIOXIDE; BAICALIN; CATION; DRUG CARRIER; FLAVONOID; LIPID; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; NANOPARTICLE;

ARTICLE; BIODEGRADABILITY; CIRCULAR DICHROISM; DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICROCOCCUS LUTEUS; PROTEIN STABILITY; SCANNING ELECTRON MICROSCOPY; ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; MALE; METABOLISM; PROCEDURES; RAT; SYNTHESIS; WISTAR RAT; X RAY DIFFRACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD-BRAIN BARRIER; CATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; LIPIDS; MALE; NANOPARTICLES; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; X-RAY DIFFRACTION;

EID: 84924971966     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.861478     Document Type: Article

References (30)

1. Béduneau A, Hindré F, Clavreul A, et al. Brain targeting using novel lipid nanovectors. J Control Release 2008;126:44-9.
2. Gururangan S, Friedman HS. Innovations in design and delivery of chemotherapy for brain tumors. Neuroimaging Clin N Am 2001;12: 583-97.
3. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drugnanoparticles? Drug Discov Today 2008;13:1099-106.
4. Jiang XY, Xin HL, Sha XY, et al. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int J Pharm 2011; 420:385-94.
5. Hu KL, Shi YB, Jiang WM, et al. Lactoferrin conjugated PEGPLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease. Int J Pharm 2011;415:273-83.
6. Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 1996; 93:14164-9.
7. Bao HM, Jin X, Li L, et al. OX26 modified heperbranchedpolyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluztion of its brain delivery ability. J Mater Sci Mater Med 2012;23:1891-901.
8. Pang ZQ, Lu W, Gao HL, et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release 2008;128:120-7.
9. Jain KK. Use of nanoparticles for drug delivery in glioblastomamultiforme. Expert Rev Neurother 2007;7:363-72.
10. Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004;12:635-41.
11. Cao YG, Mao XY, Sun CY, et al. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and antiapoptotic pathways. Brain Res Bull 2011;85:396-402.
12. Ellmann GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
13. Olivier JC, Huertas R, Lee HJ, et al. Synthesis of pegylatedimmunonanoparticles. Pharm Res 2002;19:1137-43.
14. Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugatedpegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 2005;107:428-48.
15. Yue PF, Lu XY, Zhang ZZ, et al. The study on the entrapment efficiency and in vitro release of puerarin submicronemulsion. AAPS PharmSciTech 2009;10:376-83.
16. Wang XM, He HB, Leng W, Tang X. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int J Pharm 2006;317:40-6.
17. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 1960;11: 85-9.
18. Laine AL, Huynh NT, Clavreul A, et al. Brain tumor targeting strategies via coated ferrociphenol lipid nanocapsules. Eur J Pharm Biopharm 2012;81:690-3.
19. Jain A, Chasoo G, Singh SK, et al. Transferrin-appended PEGylation nanoparticles for temozolomide delivery to brain: in-vitro characterization. J Microencapsul 2011;28:21-8.
20. Liu ZD, Zhang XH, Wu HY, et al. Preparation and evaluation of solid Lipid Nanoparticles of Baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37: 475-81.
21. Liu LH, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. J Biomaterials 2008;29:1509-17.
22. Kanayama N, Takarada T, Kimura A, et al. Poly(ethyleneglycol)-oligodeoxyribonucleotide block copolymers for affinity capillary electrophoretic separation of single-stranded DNAs with a singlebase difference. J React Funct Polym 2007;67:1373-80.
23. Bungay PM, Morrison PF, Dedrick RL. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 1990;46:105-19.
24. Bungay PF, Hsiao JK, Ball BA, et al. Quantitative microdialysis: analysis of transient and application to pharmacokinetics in brain. J Neurochem 1991;57:103-19.
25. Benveniste H, Hansen AJ, Ottosen NS. Determination of brain interstitial concentrations by microdialysis. J Neurochem 1991;57: 1741-50.
26. Liu ZD, Yang XG, Li JW, et al. Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev Ind Pharm 2007;33: 1327-31.
27. Tömböly C, Péter A, Tóth, G. In vitro quantitative study of the degradation of endomorphins. Peptides 2002;23:1573-80.
28. Sugiyama I, Sadzuka Y. Characterization of novel mixed polyethylene glycol modified liposomes. Biol Pharm Bull 2007;30: 208-11.
29. Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 2012;161: 264-73.
30. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009;66:2873-96.